DRS105963_1.png

Erlogem 150 Tablet

Therapeutic Class: ANTI NEOPLASTICS
Manufacturer:
Get Quote

Erlogem 150 Tablet is an anti-cancer medication. Epidermal growth factor receptors (EGFR) are expressed on the lung cancer cell surfaces that modulate their growth. This medicine works by binding the chemical messenger, EGFR, hence, inhibits the cancer signaling pathways mediated by EGFR. This is how it restricts further growth of the cancer cells. (N. Chimanlal Enterprises – Exporter of ONCO & Critical Care Products Mumbai INDIA)

Salt Composition: Erlotinib (150mg)
Strength: Erlotinib (150mg)
Pack Size: strip of 10 tablets
Uses: Pancreatic cancer|Non-small cell lung cancer
Table Header
Salt Composition
Erlotinib (150mg)
Strength
Erlotinib (150mg)
Pack Size
strip of 10 tablets
Uses
Pancreatic cancer|Non-small cell lung cancer
DISCLAIMER
N Chimanlal Enterprises (www.pilcare.com) is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India. Product is supplied for Tenders/ Emergency imports/ Unlicensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Product names, logos, brands and other trademarks featured or referred to are the property of their respective Trademark Holders. The information provided here is for Informational purposes only.

Product information is meant for


WholesalersSuppliersExportersDoctorsMOH Tender SuppliesHospitalsBrandCROsComparator SuppliesGenericCooperate SourcingIndividual PatientsIndian Institutional Buyers
Recently Viewed
Categories